• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IAM
Click for more information
0.00% 5.1¢

INCOME ASSET MANAGEMENT GROUP LIMITED. - Charts / Financials

Market Cap $16.87M  ! watchlist Created with Sketch. Add to my watchlist
Financial Services

Income Asset Management Group Ltd (ASX:IAM), (IAM), has seen tremendous growth into a... Income Asset Management Group Ltd (ASX:IAM), (IAM), has seen tremendous growth into a sophisticated investing solution provider. The Group delivers unique solutions in Cash, Bonds and Funds Management for sophisticated investors and professional investment managers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 16.20pm 04/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 6.1¢ 82000   1 7.9¢ 8388

Directors & Senior Management

Mr. John Nantes Executive Chairman of the Board
Mr. John Lechte Chief Executive Officer
Mr. Cameron Coleman Chief Operating Officer
Mr. Craig Swanger Executive Director
Mr. Matthew Loughnan Chief Commercial Officer
Ms. Vanessa Chidrawi Company Secretary
Mr. Simon Maidment Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
5.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.87M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 82000 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 8388 1
View Market Depth
Last trade - 16.12pm 04/10/2024 (20 minute delay) ?

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.
BCI reaches close of funding facility for salt-first part of Mardie project BCI Minerals Ltd has achieved financial close on a Syndicated Facility Agreement worth $981 million for its Mardie project in WA
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.